The Motley Fool··Prosper Junior BakinyNovo Nordisk's Subscription Model Could Unlock Massive Obesity Market Despite Lilly Competition
Novo Nordisk launches tiered subscription pricing for Wegovy to expand obesity drug access. Stock trades at attractive 11x forward earnings amid market penetration opportunity.
LLYNVOGLP-1 drugsweight loss medications